Summary
For Year 2026-27, Alkem Laboratories reports the following shareholding: Total Promoters at 51.2%, Mutual Fund at 15.57%, Insurance at 4.18%, Foreign Institutional Investors at 10.15%, Domestic Institutional Investors at 1.65%, and Retail at 17.25%. This breakdown provides a quick snapshot of ownership distribution for Alkem Laboratories in 2026-27.
Alkem Laboratories FAQs
As of 04-2026, the promoter shareholding in Alkem Laboratories stands at 51.2% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Alkem Laboratories is 10.15% and 1.65% respectively.
The retail shareholding of the Alkem Laboratories is 17.25%.
Changes in shareholding patterns of Alkem Laboratories can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Alkem Laboratories are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
Alkem Laboratories Associated Pages
